Market Tracker

04/25 5:16pm ET

Accuray Inc (NASDAQ:ARAY)

4.70
Delayed Data
As of Apr 25
 +0.05 / +1.08%
Today’s Change
4.45
Today|||52-Week Range
6.39
+2.17%
Year-to-Date
Is Accuray (ARAY) a Great Growth Stock?
Apr 13 / Zacks.com - Paid Partner Content
Accuray TomoTherapy System Starts Cancer Treatment in Africa
Apr 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.65
Today’s open4.70
Day’s range4.65 - 4.80
Volume767,569
Average volume (3 months)798,485
Market cap$385.5M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+37.25%
Earnings growth (this year)+44.16%
Earnings growth (next 5 years)-259.10%
Revenue growth (last year)+5.00%
P/E ratioNM
Price/Sales1.05
Price/Book6.34

Competitors

 Today’s
change
Today’s
% change
AXGNAxoGen Inc+0.20+1.74%
VRAYViewray Inc+0.25+3.79%
NVDQNovadaq Technologies...+0.04+0.55%
ENTLEntellus Medical Inc+0.03+0.21%
Data as of 3:59pm ET, 04/25/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.01
Annual revenue (last year)$398.8M
Annual profit (last year)-$25.5M
Net profit margin-6.40%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joshua H. Levine
Chief Operating Officer &
Executive Vice President
Kelly J. Londy
Corporate headquarters
Sunnyvale, California

Forecasts